nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—Testosterone—Estradiol—osteoporosis	0.34	1	CrCrCtD
Abiraterone—ABCC1—Zoledronate—osteoporosis	0.104	0.231	CbGbCtD
Abiraterone—ABCC1—Conjugated Estrogens—osteoporosis	0.0578	0.128	CbGbCtD
Abiraterone—ALB—Estropipate—osteoporosis	0.0564	0.125	CbGbCtD
Abiraterone—CYP2C8—Raloxifene—osteoporosis	0.0291	0.0645	CbGbCtD
Abiraterone—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0281	0.0623	CbGbCtD
Abiraterone—ALB—Estradiol—osteoporosis	0.0234	0.0519	CbGbCtD
Abiraterone—CYP2C8—Cholecalciferol—osteoporosis	0.0224	0.0498	CbGbCtD
Abiraterone—CYP2C8—Estradiol—osteoporosis	0.0181	0.0401	CbGbCtD
Abiraterone—CYP3A4—Estropipate—osteoporosis	0.0177	0.0392	CbGbCtD
Abiraterone—CYP3A4—Calcitriol—osteoporosis	0.0177	0.0392	CbGbCtD
Abiraterone—CYP2D6—Cholecalciferol—osteoporosis	0.0143	0.0318	CbGbCtD
Abiraterone—CYP3A4—Ergocalciferol—osteoporosis	0.0141	0.0313	CbGbCtD
Abiraterone—CYP3A4—Raloxifene—osteoporosis	0.0118	0.0262	CbGbCtD
Abiraterone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0114	0.0253	CbGbCtD
Abiraterone—CYP3A4—Cholecalciferol—osteoporosis	0.0091	0.0202	CbGbCtD
Abiraterone—CYP3A4—Conjugated Estrogens—osteoporosis	0.00836	0.0185	CbGbCtD
Abiraterone—CYP3A4—Estradiol—osteoporosis	0.00734	0.0163	CbGbCtD
Abiraterone—Testosterone—SHBG—osteoporosis	0.000828	0.577	CrCbGaD
Abiraterone—Testosterone—CYP19A1—osteoporosis	0.000608	0.423	CrCbGaD
Abiraterone—Infestation—Conjugated Estrogens—osteoporosis	0.000342	0.0023	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000342	0.0023	CcSEcCtD
Abiraterone—Cough—Raloxifene—osteoporosis	0.000342	0.0023	CcSEcCtD
Abiraterone—Angiopathy—Ethinyl Estradiol—osteoporosis	0.000342	0.0023	CcSEcCtD
Abiraterone—Cardiac disorder—Risedronate—osteoporosis	0.000341	0.0023	CcSEcCtD
Abiraterone—Myalgia—Alendronate—osteoporosis	0.000339	0.00229	CcSEcCtD
Abiraterone—Chest pain—Alendronate—osteoporosis	0.000339	0.00229	CcSEcCtD
Abiraterone—Haematuria—Zoledronate—osteoporosis	0.000339	0.00228	CcSEcCtD
Abiraterone—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.000337	0.00227	CcSEcCtD
Abiraterone—Dyspepsia—Etidronic acid—osteoporosis	0.000336	0.00226	CcSEcCtD
Abiraterone—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.000336	0.00226	CcSEcCtD
Abiraterone—Discomfort—Alendronate—osteoporosis	0.000335	0.00226	CcSEcCtD
Abiraterone—Hypertension—Ibandronate—osteoporosis	0.000335	0.00226	CcSEcCtD
Abiraterone—Chest pain—Raloxifene—osteoporosis	0.000334	0.00225	CcSEcCtD
Abiraterone—Myalgia—Raloxifene—osteoporosis	0.000334	0.00225	CcSEcCtD
Abiraterone—Angiopathy—Risedronate—osteoporosis	0.000333	0.00224	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000332	0.00223	CcSEcCtD
Abiraterone—Mediastinal disorder—Risedronate—osteoporosis	0.000331	0.00223	CcSEcCtD
Abiraterone—Chest pain—Ibandronate—osteoporosis	0.00033	0.00222	CcSEcCtD
Abiraterone—Myalgia—Ibandronate—osteoporosis	0.00033	0.00222	CcSEcCtD
Abiraterone—Oedema—Estropipate—osteoporosis	0.00033	0.00222	CcSEcCtD
Abiraterone—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00033	0.00222	CcSEcCtD
Abiraterone—Arrhythmia—Risedronate—osteoporosis	0.000328	0.00221	CcSEcCtD
Abiraterone—Infection—Estropipate—osteoporosis	0.000328	0.00221	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000328	0.00221	CcSEcCtD
Abiraterone—Hypertension—Calcitriol—osteoporosis	0.000328	0.00221	CcSEcCtD
Abiraterone—Constipation—Etidronic acid—osteoporosis	0.000327	0.0022	CcSEcCtD
Abiraterone—Discomfort—Ibandronate—osteoporosis	0.000327	0.0022	CcSEcCtD
Abiraterone—Cardiac disorder—Pamidronate—osteoporosis	0.000324	0.00218	CcSEcCtD
Abiraterone—Chest pain—Calcitriol—osteoporosis	0.000324	0.00218	CcSEcCtD
Abiraterone—Myalgia—Calcitriol—osteoporosis	0.000324	0.00218	CcSEcCtD
Abiraterone—Infection—Alendronate—osteoporosis	0.000323	0.00218	CcSEcCtD
Abiraterone—Mental disorder—Risedronate—osteoporosis	0.000322	0.00217	CcSEcCtD
Abiraterone—Skin disorder—Estropipate—osteoporosis	0.000321	0.00216	CcSEcCtD
Abiraterone—Discomfort—Calcitriol—osteoporosis	0.00032	0.00215	CcSEcCtD
Abiraterone—Infection—Raloxifene—osteoporosis	0.000318	0.00214	CcSEcCtD
Abiraterone—Nasopharyngitis—Estradiol—osteoporosis	0.000318	0.00214	CcSEcCtD
Abiraterone—Angiopathy—Pamidronate—osteoporosis	0.000317	0.00213	CcSEcCtD
Abiraterone—Urinary tract disorder—Zoledronate—osteoporosis	0.000315	0.00212	CcSEcCtD
Abiraterone—Mediastinal disorder—Pamidronate—osteoporosis	0.000315	0.00212	CcSEcCtD
Abiraterone—Infection—Ibandronate—osteoporosis	0.000315	0.00212	CcSEcCtD
Abiraterone—Connective tissue disorder—Zoledronate—osteoporosis	0.000314	0.00211	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Estradiol—osteoporosis	0.000314	0.00211	CcSEcCtD
Abiraterone—Urethral disorder—Zoledronate—osteoporosis	0.000313	0.00211	CcSEcCtD
Abiraterone—Skin disorder—Raloxifene—osteoporosis	0.000311	0.00209	CcSEcCtD
Abiraterone—Skin disorder—Ibandronate—osteoporosis	0.000308	0.00207	CcSEcCtD
Abiraterone—Skin disorder—Calcitriol—osteoporosis	0.000301	0.00203	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000301	0.00203	CcSEcCtD
Abiraterone—Insomnia—Estropipate—osteoporosis	0.000299	0.00201	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000296	0.002	CcSEcCtD
Abiraterone—Cardiac disorder—Zoledronate—osteoporosis	0.000296	0.00199	CcSEcCtD
Abiraterone—Anaemia—Risedronate—osteoporosis	0.000296	0.00199	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000292	0.00196	CcSEcCtD
Abiraterone—Dyspepsia—Estropipate—osteoporosis	0.000291	0.00196	CcSEcCtD
Abiraterone—Angiopathy—Zoledronate—osteoporosis	0.00029	0.00195	CcSEcCtD
Abiraterone—Insomnia—Raloxifene—osteoporosis	0.000289	0.00195	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000289	0.00194	CcSEcCtD
Abiraterone—Mediastinal disorder—Zoledronate—osteoporosis	0.000288	0.00194	CcSEcCtD
Abiraterone—Insomnia—Ibandronate—osteoporosis	0.000287	0.00193	CcSEcCtD
Abiraterone—Dyspepsia—Alendronate—osteoporosis	0.000286	0.00193	CcSEcCtD
Abiraterone—Cough—Ethinyl Estradiol—osteoporosis	0.000286	0.00193	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Estradiol—osteoporosis	0.000286	0.00192	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Estropipate—osteoporosis	0.000285	0.00192	CcSEcCtD
Abiraterone—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000285	0.00192	CcSEcCtD
Abiraterone—Arrhythmia—Zoledronate—osteoporosis	0.000285	0.00192	CcSEcCtD
Abiraterone—Fatigue—Estropipate—osteoporosis	0.000285	0.00192	CcSEcCtD
Abiraterone—Pollakiuria—Estradiol—osteoporosis	0.000284	0.00191	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000283	0.0019	CcSEcCtD
Abiraterone—Constipation—Estropipate—osteoporosis	0.000283	0.0019	CcSEcCtD
Abiraterone—Dyspepsia—Raloxifene—osteoporosis	0.000282	0.0019	CcSEcCtD
Abiraterone—Anaemia—Pamidronate—osteoporosis	0.000281	0.00189	CcSEcCtD
Abiraterone—Insomnia—Calcitriol—osteoporosis	0.000281	0.00189	CcSEcCtD
Abiraterone—Mental disorder—Zoledronate—osteoporosis	0.00028	0.00188	CcSEcCtD
Abiraterone—Cough—Risedronate—osteoporosis	0.000279	0.00188	CcSEcCtD
Abiraterone—Dyspepsia—Ibandronate—osteoporosis	0.000279	0.00188	CcSEcCtD
Abiraterone—Angiopathy—Conjugated Estrogens—osteoporosis	0.000279	0.00188	CcSEcCtD
Abiraterone—Constipation—Alendronate—osteoporosis	0.000278	0.00187	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000277	0.00187	CcSEcCtD
Abiraterone—Hyperglycaemia—Estradiol—osteoporosis	0.000277	0.00187	CcSEcCtD
Abiraterone—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000277	0.00186	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000276	0.00186	CcSEcCtD
Abiraterone—Hypertension—Risedronate—osteoporosis	0.000276	0.00186	CcSEcCtD
Abiraterone—Discomfort—Ethinyl Estradiol—osteoporosis	0.000276	0.00186	CcSEcCtD
Abiraterone—Pneumonia—Estradiol—osteoporosis	0.000276	0.00185	CcSEcCtD
Abiraterone—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000275	0.00185	CcSEcCtD
Abiraterone—Infestation NOS—Estradiol—osteoporosis	0.000274	0.00184	CcSEcCtD
Abiraterone—Infestation—Estradiol—osteoporosis	0.000274	0.00184	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000274	0.00184	CcSEcCtD
Abiraterone—Fatigue—Ibandronate—osteoporosis	0.000273	0.00184	CcSEcCtD
Abiraterone—Myalgia—Risedronate—osteoporosis	0.000272	0.00183	CcSEcCtD
Abiraterone—Chest pain—Risedronate—osteoporosis	0.000272	0.00183	CcSEcCtD
Abiraterone—Constipation—Ibandronate—osteoporosis	0.000271	0.00182	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00027	0.00182	CcSEcCtD
Abiraterone—Acute coronary syndrome—Estradiol—osteoporosis	0.00027	0.00182	CcSEcCtD
Abiraterone—Mental disorder—Conjugated Estrogens—osteoporosis	0.000269	0.00181	CcSEcCtD
Abiraterone—Myocardial infarction—Estradiol—osteoporosis	0.000269	0.00181	CcSEcCtD
Abiraterone—Oedema—Ethinyl Estradiol—osteoporosis	0.000268	0.0018	CcSEcCtD
Abiraterone—Urinary tract infection—Estradiol—osteoporosis	0.000266	0.00179	CcSEcCtD
Abiraterone—Infection—Ethinyl Estradiol—osteoporosis	0.000266	0.00179	CcSEcCtD
Abiraterone—Cough—Pamidronate—osteoporosis	0.000265	0.00179	CcSEcCtD
Abiraterone—Constipation—Calcitriol—osteoporosis	0.000265	0.00179	CcSEcCtD
Abiraterone—Hypertension—Pamidronate—osteoporosis	0.000263	0.00177	CcSEcCtD
Abiraterone—Diarrhoea—Etidronic acid—osteoporosis	0.000261	0.00176	CcSEcCtD
Abiraterone—Haematuria—Estradiol—osteoporosis	0.000261	0.00176	CcSEcCtD
Abiraterone—Body temperature increased—Estropipate—osteoporosis	0.000261	0.00176	CcSEcCtD
Abiraterone—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00026	0.00175	CcSEcCtD
Abiraterone—Infection—Risedronate—osteoporosis	0.000259	0.00175	CcSEcCtD
Abiraterone—Myalgia—Pamidronate—osteoporosis	0.000259	0.00174	CcSEcCtD
Abiraterone—Body temperature increased—Alendronate—osteoporosis	0.000257	0.00173	CcSEcCtD
Abiraterone—Anaemia—Zoledronate—osteoporosis	0.000257	0.00173	CcSEcCtD
Abiraterone—Discomfort—Pamidronate—osteoporosis	0.000256	0.00172	CcSEcCtD
Abiraterone—Skin disorder—Risedronate—osteoporosis	0.000254	0.00171	CcSEcCtD
Abiraterone—Body temperature increased—Raloxifene—osteoporosis	0.000253	0.0017	CcSEcCtD
Abiraterone—Body temperature increased—Ibandronate—osteoporosis	0.00025	0.00169	CcSEcCtD
Abiraterone—Oedema—Pamidronate—osteoporosis	0.000248	0.00167	CcSEcCtD
Abiraterone—Infection—Pamidronate—osteoporosis	0.000247	0.00166	CcSEcCtD
Abiraterone—Body temperature increased—Calcitriol—osteoporosis	0.000245	0.00165	CcSEcCtD
Abiraterone—Urinary tract disorder—Estradiol—osteoporosis	0.000243	0.00163	CcSEcCtD
Abiraterone—Vomiting—Etidronic acid—osteoporosis	0.000243	0.00163	CcSEcCtD
Abiraterone—Cough—Zoledronate—osteoporosis	0.000242	0.00163	CcSEcCtD
Abiraterone—Connective tissue disorder—Estradiol—osteoporosis	0.000242	0.00163	CcSEcCtD
Abiraterone—Urethral disorder—Estradiol—osteoporosis	0.000241	0.00162	CcSEcCtD
Abiraterone—Rash—Etidronic acid—osteoporosis	0.000241	0.00162	CcSEcCtD
Abiraterone—Dermatitis—Etidronic acid—osteoporosis	0.000241	0.00162	CcSEcCtD
Abiraterone—Hypertension—Zoledronate—osteoporosis	0.00024	0.00161	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000238	0.0016	CcSEcCtD
Abiraterone—Asthenia—Estropipate—osteoporosis	0.000237	0.0016	CcSEcCtD
Abiraterone—Chest pain—Zoledronate—osteoporosis	0.000237	0.00159	CcSEcCtD
Abiraterone—Myalgia—Zoledronate—osteoporosis	0.000237	0.00159	CcSEcCtD
Abiraterone—Insomnia—Risedronate—osteoporosis	0.000236	0.00159	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000235	0.00158	CcSEcCtD
Abiraterone—Discomfort—Zoledronate—osteoporosis	0.000234	0.00157	CcSEcCtD
Abiraterone—Asthenia—Alendronate—osteoporosis	0.000233	0.00157	CcSEcCtD
Abiraterone—Cough—Conjugated Estrogens—osteoporosis	0.000233	0.00157	CcSEcCtD
Abiraterone—Dyspnoea—Risedronate—osteoporosis	0.000233	0.00157	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000231	0.00156	CcSEcCtD
Abiraterone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000231	0.00155	CcSEcCtD
Abiraterone—Dyspepsia—Risedronate—osteoporosis	0.00023	0.00155	CcSEcCtD
Abiraterone—Constipation—Ethinyl Estradiol—osteoporosis	0.000229	0.00154	CcSEcCtD
Abiraterone—Cardiac disorder—Estradiol—osteoporosis	0.000228	0.00154	CcSEcCtD
Abiraterone—Myalgia—Conjugated Estrogens—osteoporosis	0.000228	0.00153	CcSEcCtD
Abiraterone—Chest pain—Conjugated Estrogens—osteoporosis	0.000228	0.00153	CcSEcCtD
Abiraterone—Asthenia—Ibandronate—osteoporosis	0.000227	0.00153	CcSEcCtD
Abiraterone—Oedema—Zoledronate—osteoporosis	0.000227	0.00153	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000226	0.00152	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000226	0.00152	CcSEcCtD
Abiraterone—Diarrhoea—Estropipate—osteoporosis	0.000226	0.00152	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000225	0.00152	CcSEcCtD
Abiraterone—Infection—Zoledronate—osteoporosis	0.000225	0.00152	CcSEcCtD
Abiraterone—Fatigue—Risedronate—osteoporosis	0.000225	0.00152	CcSEcCtD
Abiraterone—Insomnia—Pamidronate—osteoporosis	0.000224	0.00151	CcSEcCtD
Abiraterone—Constipation—Risedronate—osteoporosis	0.000223	0.0015	CcSEcCtD
Abiraterone—Angiopathy—Estradiol—osteoporosis	0.000223	0.0015	CcSEcCtD
Abiraterone—Diarrhoea—Alendronate—osteoporosis	0.000223	0.0015	CcSEcCtD
Abiraterone—Asthenia—Calcitriol—osteoporosis	0.000223	0.0015	CcSEcCtD
Abiraterone—Mediastinal disorder—Estradiol—osteoporosis	0.000222	0.00149	CcSEcCtD
Abiraterone—Dyspnoea—Pamidronate—osteoporosis	0.000221	0.00149	CcSEcCtD
Abiraterone—Skin disorder—Zoledronate—osteoporosis	0.00022	0.00148	CcSEcCtD
Abiraterone—Diarrhoea—Raloxifene—osteoporosis	0.000219	0.00147	CcSEcCtD
Abiraterone—Dyspepsia—Pamidronate—osteoporosis	0.000218	0.00147	CcSEcCtD
Abiraterone—Oedema—Conjugated Estrogens—osteoporosis	0.000218	0.00147	CcSEcCtD
Abiraterone—Infection—Conjugated Estrogens—osteoporosis	0.000217	0.00146	CcSEcCtD
Abiraterone—Diarrhoea—Ibandronate—osteoporosis	0.000217	0.00146	CcSEcCtD
Abiraterone—Mental disorder—Estradiol—osteoporosis	0.000215	0.00145	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000214	0.00144	CcSEcCtD
Abiraterone—Fatigue—Pamidronate—osteoporosis	0.000214	0.00144	CcSEcCtD
Abiraterone—Constipation—Pamidronate—osteoporosis	0.000212	0.00143	CcSEcCtD
Abiraterone—Diarrhoea—Calcitriol—osteoporosis	0.000212	0.00143	CcSEcCtD
Abiraterone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000212	0.00143	CcSEcCtD
Abiraterone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000212	0.00143	CcSEcCtD
Abiraterone—Vomiting—Estropipate—osteoporosis	0.00021	0.00141	CcSEcCtD
Abiraterone—Rash—Estropipate—osteoporosis	0.000208	0.0014	CcSEcCtD
Abiraterone—Dermatitis—Estropipate—osteoporosis	0.000208	0.0014	CcSEcCtD
Abiraterone—Vomiting—Alendronate—osteoporosis	0.000207	0.00139	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000207	0.00139	CcSEcCtD
Abiraterone—Body temperature increased—Risedronate—osteoporosis	0.000206	0.00139	CcSEcCtD
Abiraterone—Rash—Alendronate—osteoporosis	0.000205	0.00138	CcSEcCtD
Abiraterone—Insomnia—Zoledronate—osteoporosis	0.000205	0.00138	CcSEcCtD
Abiraterone—Dermatitis—Alendronate—osteoporosis	0.000205	0.00138	CcSEcCtD
Abiraterone—Vomiting—Raloxifene—osteoporosis	0.000203	0.00137	CcSEcCtD
Abiraterone—Dyspnoea—Zoledronate—osteoporosis	0.000202	0.00136	CcSEcCtD
Abiraterone—Rash—Raloxifene—osteoporosis	0.000202	0.00136	CcSEcCtD
Abiraterone—Dermatitis—Raloxifene—osteoporosis	0.000202	0.00136	CcSEcCtD
Abiraterone—Vomiting—Ibandronate—osteoporosis	0.000201	0.00136	CcSEcCtD
Abiraterone—Rash—Ibandronate—osteoporosis	0.0002	0.00134	CcSEcCtD
Abiraterone—Dermatitis—Ibandronate—osteoporosis	0.0002	0.00134	CcSEcCtD
Abiraterone—Dyspepsia—Zoledronate—osteoporosis	0.0002	0.00134	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000199	0.00134	CcSEcCtD
Abiraterone—Insomnia—Conjugated Estrogens—osteoporosis	0.000197	0.00133	CcSEcCtD
Abiraterone—Vomiting—Calcitriol—osteoporosis	0.000197	0.00133	CcSEcCtD
Abiraterone—Body temperature increased—Pamidronate—osteoporosis	0.000196	0.00132	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000196	0.00132	CcSEcCtD
Abiraterone—Rash—Calcitriol—osteoporosis	0.000196	0.00132	CcSEcCtD
Abiraterone—Fatigue—Zoledronate—osteoporosis	0.000195	0.00132	CcSEcCtD
Abiraterone—Dermatitis—Calcitriol—osteoporosis	0.000195	0.00132	CcSEcCtD
Abiraterone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000195	0.00131	CcSEcCtD
Abiraterone—Constipation—Zoledronate—osteoporosis	0.000194	0.00131	CcSEcCtD
Abiraterone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000192	0.00129	CcSEcCtD
Abiraterone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000192	0.00129	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000188	0.00127	CcSEcCtD
Abiraterone—Fatigue—Conjugated Estrogens—osteoporosis	0.000188	0.00127	CcSEcCtD
Abiraterone—Asthenia—Risedronate—osteoporosis	0.000187	0.00126	CcSEcCtD
Abiraterone—Cough—Estradiol—osteoporosis	0.000187	0.00126	CcSEcCtD
Abiraterone—Constipation—Conjugated Estrogens—osteoporosis	0.000187	0.00126	CcSEcCtD
Abiraterone—Hypertension—Estradiol—osteoporosis	0.000185	0.00124	CcSEcCtD
Abiraterone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000183	0.00123	CcSEcCtD
Abiraterone—Chest pain—Estradiol—osteoporosis	0.000182	0.00123	CcSEcCtD
Abiraterone—Myalgia—Estradiol—osteoporosis	0.000182	0.00123	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000181	0.00122	CcSEcCtD
Abiraterone—Discomfort—Estradiol—osteoporosis	0.00018	0.00121	CcSEcCtD
Abiraterone—Body temperature increased—Zoledronate—osteoporosis	0.000179	0.00121	CcSEcCtD
Abiraterone—Diarrhoea—Risedronate—osteoporosis	0.000179	0.0012	CcSEcCtD
Abiraterone—Asthenia—Pamidronate—osteoporosis	0.000178	0.0012	CcSEcCtD
Abiraterone—Oedema—Estradiol—osteoporosis	0.000175	0.00118	CcSEcCtD
Abiraterone—Infection—Estradiol—osteoporosis	0.000174	0.00117	CcSEcCtD
Abiraterone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000173	0.00116	CcSEcCtD
Abiraterone—Vomiting—Ethinyl Estradiol—osteoporosis	0.00017	0.00115	CcSEcCtD
Abiraterone—Diarrhoea—Pamidronate—osteoporosis	0.00017	0.00114	CcSEcCtD
Abiraterone—Skin disorder—Estradiol—osteoporosis	0.00017	0.00114	CcSEcCtD
Abiraterone—Rash—Ethinyl Estradiol—osteoporosis	0.000169	0.00114	CcSEcCtD
Abiraterone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000169	0.00114	CcSEcCtD
Abiraterone—Vomiting—Risedronate—osteoporosis	0.000166	0.00112	CcSEcCtD
Abiraterone—Rash—Risedronate—osteoporosis	0.000165	0.00111	CcSEcCtD
Abiraterone—Dermatitis—Risedronate—osteoporosis	0.000164	0.00111	CcSEcCtD
Abiraterone—Asthenia—Zoledronate—osteoporosis	0.000163	0.0011	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000159	0.00107	CcSEcCtD
Abiraterone—Insomnia—Estradiol—osteoporosis	0.000158	0.00106	CcSEcCtD
Abiraterone—Vomiting—Pamidronate—osteoporosis	0.000158	0.00106	CcSEcCtD
Abiraterone—Asthenia—Conjugated Estrogens—osteoporosis	0.000157	0.00105	CcSEcCtD
Abiraterone—Rash—Pamidronate—osteoporosis	0.000157	0.00105	CcSEcCtD
Abiraterone—Dermatitis—Pamidronate—osteoporosis	0.000156	0.00105	CcSEcCtD
Abiraterone—Dyspnoea—Estradiol—osteoporosis	0.000156	0.00105	CcSEcCtD
Abiraterone—Diarrhoea—Zoledronate—osteoporosis	0.000155	0.00104	CcSEcCtD
Abiraterone—Dyspepsia—Estradiol—osteoporosis	0.000154	0.00104	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000151	0.00102	CcSEcCtD
Abiraterone—Fatigue—Estradiol—osteoporosis	0.000151	0.00101	CcSEcCtD
Abiraterone—Constipation—Estradiol—osteoporosis	0.000149	0.00101	CcSEcCtD
Abiraterone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000149	0.00101	CcSEcCtD
Abiraterone—Vomiting—Zoledronate—osteoporosis	0.000144	0.00097	CcSEcCtD
Abiraterone—Rash—Zoledronate—osteoporosis	0.000143	0.000962	CcSEcCtD
Abiraterone—Dermatitis—Zoledronate—osteoporosis	0.000143	0.000961	CcSEcCtD
Abiraterone—Vomiting—Conjugated Estrogens—osteoporosis	0.000139	0.000934	CcSEcCtD
Abiraterone—Body temperature increased—Estradiol—osteoporosis	0.000138	0.00093	CcSEcCtD
Abiraterone—Rash—Conjugated Estrogens—osteoporosis	0.000138	0.000927	CcSEcCtD
Abiraterone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000138	0.000926	CcSEcCtD
Abiraterone—Asthenia—Estradiol—osteoporosis	0.000125	0.000844	CcSEcCtD
Abiraterone—Diarrhoea—Estradiol—osteoporosis	0.00012	0.000805	CcSEcCtD
Abiraterone—Vomiting—Estradiol—osteoporosis	0.000111	0.000748	CcSEcCtD
Abiraterone—Rash—Estradiol—osteoporosis	0.00011	0.000742	CcSEcCtD
Abiraterone—Dermatitis—Estradiol—osteoporosis	0.00011	0.000741	CcSEcCtD
Abiraterone—CYP17A1—Metabolism—OXCT1—osteoporosis	7.55e-05	0.00128	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.53e-05	0.00128	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	7.5e-05	0.00127	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—CAP1—osteoporosis	7.48e-05	0.00127	CbGpPWpGaD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	7.42e-05	0.00126	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SOST—osteoporosis	7.38e-05	0.00125	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PKM—osteoporosis	7.38e-05	0.00125	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—MGLL—osteoporosis	7.36e-05	0.00125	CbGpPWpGaD
Abiraterone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.32e-05	0.00124	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—ENO1—osteoporosis	7.29e-05	0.00123	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	7.18e-05	0.00122	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PSMA2—osteoporosis	7.18e-05	0.00122	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PSMA5—osteoporosis	7.18e-05	0.00122	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	7.14e-05	0.00121	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ANTXR2—osteoporosis	7e-05	0.00119	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PGLS—osteoporosis	7e-05	0.00119	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	6.98e-05	0.00118	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.94e-05	0.00118	CbGpPWpGaD
Abiraterone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.82e-05	0.00116	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	6.8e-05	0.00115	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.78e-05	0.00115	CbGpPWpGaD
Abiraterone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.74e-05	0.00114	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—IGF1—osteoporosis	6.31e-05	0.00107	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—IDH2—osteoporosis	6.26e-05	0.00106	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	6.18e-05	0.00105	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—FDPS—osteoporosis	6.18e-05	0.00105	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PKM—osteoporosis	6.18e-05	0.00105	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	6.08e-05	0.00103	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.02e-05	0.00102	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	6.01e-05	0.00102	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	6e-05	0.00102	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	5.95e-05	0.00101	CbGpPWpGaD
Abiraterone—ABCC1—Disease—GSN—osteoporosis	5.95e-05	0.00101	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MGLL—osteoporosis	5.95e-05	0.00101	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP27A1—osteoporosis	5.88e-05	0.000997	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	5.87e-05	0.000995	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PGLS—osteoporosis	5.86e-05	0.000993	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GPD2—osteoporosis	5.86e-05	0.000993	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CYP19A1—osteoporosis	5.82e-05	0.000987	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ACP5—osteoporosis	5.72e-05	0.00097	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL1B—osteoporosis	5.68e-05	0.000962	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.65e-05	0.000957	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.59e-05	0.000946	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.55e-05	0.000941	CbGpPWpGaD
Abiraterone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.53e-05	0.000937	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.44e-05	0.000922	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PLEK—osteoporosis	5.44e-05	0.000921	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—ANXA2—osteoporosis	5.44e-05	0.000921	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.41e-05	0.000917	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PNP—osteoporosis	5.36e-05	0.000908	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ATIC—osteoporosis	5.36e-05	0.000908	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—TPI1—osteoporosis	5.32e-05	0.000902	CbGpPWpGaD
Abiraterone—ABCC1—Disease—LRP5—osteoporosis	5.17e-05	0.000877	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	5.07e-05	0.000858	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—P4HB—osteoporosis	5e-05	0.000848	CbGpPWpGaD
Abiraterone—ABCC1—Disease—LRP6—osteoporosis	4.95e-05	0.000839	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GAPDH—osteoporosis	4.91e-05	0.000832	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	4.89e-05	0.000828	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	4.82e-05	0.000817	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—RAP1A—osteoporosis	4.78e-05	0.00081	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—ADCY5—osteoporosis	4.76e-05	0.000806	CbGpPWpGaD
Abiraterone—ABCC1—Disease—LTF—osteoporosis	4.76e-05	0.000806	CbGpPWpGaD
Abiraterone—ABCC1—Disease—RPL24—osteoporosis	4.76e-05	0.000806	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GPX1—osteoporosis	4.74e-05	0.000804	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.71e-05	0.000798	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TLN1—osteoporosis	4.69e-05	0.000794	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VCL—osteoporosis	4.62e-05	0.000783	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CA2—osteoporosis	4.56e-05	0.000772	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—OXCT1—osteoporosis	4.56e-05	0.000772	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	4.51e-05	0.000765	CbGpPWpGaD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.46e-05	0.000756	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—MGLL—osteoporosis	4.44e-05	0.000752	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—MTHFR—osteoporosis	4.38e-05	0.000742	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.35e-05	0.000737	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.33e-05	0.000733	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.19e-05	0.000709	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.17e-05	0.000707	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ACP5—osteoporosis	4.12e-05	0.000698	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TNF—osteoporosis	4.12e-05	0.000698	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	4.09e-05	0.000693	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ENO1—osteoporosis	3.87e-05	0.000655	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—RAP1A—osteoporosis	3.86e-05	0.000655	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TPI1—osteoporosis	3.83e-05	0.000649	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PSMA5—osteoporosis	3.81e-05	0.000645	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PSMA2—osteoporosis	3.81e-05	0.000645	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—TGFB1—osteoporosis	3.78e-05	0.000641	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—IDH2—osteoporosis	3.78e-05	0.00064	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.7e-05	0.000627	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.68e-05	0.000623	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.62e-05	0.000613	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	3.61e-05	0.000611	CbGpPWpGaD
Abiraterone—ABCC1—Disease—P4HB—osteoporosis	3.6e-05	0.000611	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—POMC—osteoporosis	3.58e-05	0.000606	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP27A1—osteoporosis	3.55e-05	0.000601	CbGpPWpGaD
Abiraterone—ABCC1—Disease—GAPDH—osteoporosis	3.54e-05	0.000599	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—FGA—osteoporosis	3.5e-05	0.000594	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—POMC—osteoporosis	3.5e-05	0.000593	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ACP5—osteoporosis	3.45e-05	0.000585	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.41e-05	0.000578	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PKM—osteoporosis	3.37e-05	0.000572	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—FDPS—osteoporosis	3.37e-05	0.000572	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NFATC1—osteoporosis	3.36e-05	0.000569	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PKM—osteoporosis	3.36e-05	0.000568	CbGpPWpGaD
Abiraterone—ALB—Metabolism—FDPS—osteoporosis	3.36e-05	0.000568	CbGpPWpGaD
Abiraterone—ABCC1—Disease—DKK1—osteoporosis	3.33e-05	0.000565	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL6—osteoporosis	3.33e-05	0.000564	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—TNF—osteoporosis	3.27e-05	0.000555	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.25e-05	0.000551	CbGpPWpGaD
Abiraterone—ABCC1—Disease—WNT1—osteoporosis	3.21e-05	0.000544	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—TPI1—osteoporosis	3.21e-05	0.000544	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PGLS—osteoporosis	3.2e-05	0.000542	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GPD2—osteoporosis	3.2e-05	0.000542	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.2e-05	0.000541	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—FGB—osteoporosis	3.19e-05	0.00054	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PGLS—osteoporosis	3.18e-05	0.000539	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GPD2—osteoporosis	3.18e-05	0.000539	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.15e-05	0.000534	CbGpPWpGaD
Abiraterone—ABCC1—Disease—FGA—osteoporosis	3.12e-05	0.000529	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP19A1—osteoporosis	3.09e-05	0.000524	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—P4HB—osteoporosis	3.02e-05	0.000511	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GAPDH—osteoporosis	2.96e-05	0.000502	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—POMC—osteoporosis	2.94e-05	0.000498	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ATIC—osteoporosis	2.93e-05	0.000496	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PNP—osteoporosis	2.93e-05	0.000496	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ATIC—osteoporosis	2.91e-05	0.000493	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PNP—osteoporosis	2.91e-05	0.000493	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—RAP1A—osteoporosis	2.89e-05	0.000489	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.8e-05	0.000474	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ENO1—osteoporosis	2.78e-05	0.000472	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PKM—osteoporosis	2.77e-05	0.000469	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—FDPS—osteoporosis	2.77e-05	0.000469	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PSMA2—osteoporosis	2.74e-05	0.000465	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PSMA5—osteoporosis	2.74e-05	0.000465	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.64e-05	0.000448	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GPD2—osteoporosis	2.63e-05	0.000445	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PGLS—osteoporosis	2.63e-05	0.000445	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CALCA—osteoporosis	2.56e-05	0.000433	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ADCY5—osteoporosis	2.53e-05	0.000428	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GPX1—osteoporosis	2.52e-05	0.000426	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.52e-05	0.000426	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—OXCT1—osteoporosis	2.49e-05	0.000422	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CA2—osteoporosis	2.49e-05	0.000422	CbGpPWpGaD
Abiraterone—ALB—Metabolism—OXCT1—osteoporosis	2.47e-05	0.000419	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CA2—osteoporosis	2.47e-05	0.000419	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MGLL—osteoporosis	2.42e-05	0.000411	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MGLL—osteoporosis	2.41e-05	0.000408	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ATIC—osteoporosis	2.4e-05	0.000407	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PNP—osteoporosis	2.4e-05	0.000407	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ENO1—osteoporosis	2.33e-05	0.000395	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—MTHFR—osteoporosis	2.32e-05	0.000394	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KL—osteoporosis	2.32e-05	0.000393	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PSMA2—osteoporosis	2.3e-05	0.000389	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PSMA5—osteoporosis	2.3e-05	0.000389	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.29e-05	0.000387	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.27e-05	0.000385	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—IDH2—osteoporosis	2.06e-05	0.000349	CbGpPWpGaD
Abiraterone—ALB—Metabolism—IDH2—osteoporosis	2.05e-05	0.000347	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—OXCT1—osteoporosis	2.04e-05	0.000346	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CA2—osteoporosis	2.04e-05	0.000346	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MGLL—osteoporosis	1.99e-05	0.000337	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.94e-05	0.000328	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP27A1—osteoporosis	1.93e-05	0.000327	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—POMC—osteoporosis	1.92e-05	0.000325	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ACP5—osteoporosis	1.89e-05	0.000319	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ACP5—osteoporosis	1.87e-05	0.000318	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP19A1—osteoporosis	1.86e-05	0.000316	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.86e-05	0.000315	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—POMC—osteoporosis	1.86e-05	0.000315	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.85e-05	0.000314	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ADCY5—osteoporosis	1.82e-05	0.000308	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PKM—osteoporosis	1.81e-05	0.000307	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—FDPS—osteoporosis	1.81e-05	0.000307	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.77e-05	0.000299	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TPI1—osteoporosis	1.75e-05	0.000297	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TPI1—osteoporosis	1.74e-05	0.000295	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GPD2—osteoporosis	1.72e-05	0.000291	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PGLS—osteoporosis	1.72e-05	0.000291	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—IDH2—osteoporosis	1.69e-05	0.000287	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.68e-05	0.000284	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTHFR—osteoporosis	1.67e-05	0.000283	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—P4HB—osteoporosis	1.65e-05	0.000279	CbGpPWpGaD
Abiraterone—ALB—Metabolism—P4HB—osteoporosis	1.64e-05	0.000278	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GAPDH—osteoporosis	1.62e-05	0.000274	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GAPDH—osteoporosis	1.61e-05	0.000273	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IRS2—osteoporosis	1.59e-05	0.00027	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.59e-05	0.00027	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—RAP1A—osteoporosis	1.58e-05	0.000267	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ATIC—osteoporosis	1.57e-05	0.000266	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PNP—osteoporosis	1.57e-05	0.000266	CbGpPWpGaD
Abiraterone—ALB—Metabolism—RAP1A—osteoporosis	1.57e-05	0.000265	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ACP5—osteoporosis	1.55e-05	0.000262	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ADCY5—osteoporosis	1.52e-05	0.000258	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GPX1—osteoporosis	1.52e-05	0.000257	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IGF1—osteoporosis	1.44e-05	0.000245	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TPI1—osteoporosis	1.44e-05	0.000244	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—MTHFR—osteoporosis	1.4e-05	0.000237	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IRS1—osteoporosis	1.39e-05	0.000235	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.37e-05	0.000233	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.37e-05	0.000231	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—P4HB—osteoporosis	1.35e-05	0.000229	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CA2—osteoporosis	1.34e-05	0.000226	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—OXCT1—osteoporosis	1.34e-05	0.000226	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GAPDH—osteoporosis	1.33e-05	0.000225	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6R—osteoporosis	1.31e-05	0.000221	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MGLL—osteoporosis	1.3e-05	0.00022	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—RAP1A—osteoporosis	1.29e-05	0.000219	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ENO1—osteoporosis	1.27e-05	0.000216	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ENO1—osteoporosis	1.27e-05	0.000215	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PSMA5—osteoporosis	1.25e-05	0.000213	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PSMA2—osteoporosis	1.25e-05	0.000213	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PSMA5—osteoporosis	1.25e-05	0.000211	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PSMA2—osteoporosis	1.25e-05	0.000211	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—POMC—osteoporosis	1.12e-05	0.00019	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—IDH2—osteoporosis	1.11e-05	0.000187	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ENO1—osteoporosis	1.05e-05	0.000177	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.04e-05	0.000176	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PSMA2—osteoporosis	1.03e-05	0.000175	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PSMA5—osteoporosis	1.03e-05	0.000175	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.02e-05	0.000172	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP19A1—osteoporosis	1.01e-05	0.000172	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ACP5—osteoporosis	1.01e-05	0.000171	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TPI1—osteoporosis	9.41e-06	0.000159	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—P4HB—osteoporosis	8.85e-06	0.00015	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GAPDH—osteoporosis	8.68e-06	0.000147	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB1—osteoporosis	8.65e-06	0.000147	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—RAP1A—osteoporosis	8.46e-06	0.000143	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.36e-06	0.000142	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ADCY5—osteoporosis	8.32e-06	0.000141	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GPX1—osteoporosis	8.29e-06	0.00014	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ADCY5—osteoporosis	8.27e-06	0.00014	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GPX1—osteoporosis	8.24e-06	0.00014	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—osteoporosis	7.73e-06	0.000131	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TGFB1—osteoporosis	7.72e-06	0.000131	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTHFR—osteoporosis	7.65e-06	0.00013	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTHFR—osteoporosis	7.61e-06	0.000129	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ENO1—osteoporosis	6.84e-06	0.000116	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ADCY5—osteoporosis	6.83e-06	0.000116	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GPX1—osteoporosis	6.81e-06	0.000115	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PSMA2—osteoporosis	6.74e-06	0.000114	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PSMA5—osteoporosis	6.74e-06	0.000114	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTHFR—osteoporosis	6.28e-06	0.000106	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—POMC—osteoporosis	6.12e-06	0.000104	CbGpPWpGaD
Abiraterone—ALB—Metabolism—POMC—osteoporosis	6.08e-06	0.000103	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—osteoporosis	5.81e-06	9.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.46e-06	9.26e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—POMC—osteoporosis	5.02e-06	8.51e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ADCY5—osteoporosis	4.47e-06	7.57e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GPX1—osteoporosis	4.45e-06	7.54e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTHFR—osteoporosis	4.11e-06	6.96e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—POMC—osteoporosis	3.28e-06	5.56e-05	CbGpPWpGaD
